The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Advocacy Is Central to Patient Care, Distinguished Lecturer Says

Advocacy Is Central to Patient Care, Distinguished Lecturer Says

December 12, 2022 • By Thomas R. Collins

  • Tweet
  • Email
Print-Friendly Version / Save PDF

PHILADELPHIA—When she saw vaping taking hold at a middle school, heightening the risk of turning children into smokers as well as boosting the risk of rheumatic disease, Kamala Nola, PharmD, MS, went to work. Dr. Nola, associate dean of academic affairs at Lipscomb University, Nashville, called the Tennessee Pharmacists Association to express her concern.

You Might Also Like
  • Channel Policy Frustrations into Advocacy to Improve Patient Care
  • Why Fellows Should Care about Advocacy
  • Why Fellows Should Care about ACR Advocacy
Also By This Author
  • Tofacitinib with Methotrexate Not Inferior to Adalimumab with Methotrexate

“This is not good,” she told the association. Soon, she was speaking at a press conference on the topic alongside state legislators, who wanted to introduce legislative language on tobacco use, vaping and related comorbid conditions.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“I went in and talked not just as a health professional, but as a mom and someone who cares for patients,” said Dr. Nola, recalling the occasion in a Distinguished Lecture at ACR Convergence 2022. “That passion came through, and it plays a role.”

In her talk, Dr. Nola emphasized that healthcare professionals should “play to your strengths” and speak out and take action on topics they feel strongly about. And she asked the audience to reconsider the concept of advocacy: It’s not just overt government-related activity, she stressed, but everyday actions as well.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“We bring the role of an advocate with lots of differing strengths that we have,” she said. “It doesn’t have to be just a communicator, just a learner, an analytic person or an interconnector. Whatever those strengths are, they are all related to advocacy.

“The way we give drug information, the way we give instructions when they’re discharged from the hospital after knee replacement—those are advocacy pieces,” she said.

Fueling Advocacy with Collegiality

The culture of the medical field can act as a kind of advocacy fuel, she suggested. Attending the American Juvenile Arthritis Organization meeting in 1998 was a seminal moment for her, leading to lifelong relationships with mentors and others interested in advocacy.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“That conference changed my life,” she said. “As a result of that meeting, my husband and I made a decision as a family that we would always commit to working with those who have arthritis.”

Attending conferences still feeds into her advocacy mentality, she said.

“When I come to this meeting and when I go my Tennessee Pharmacists Association meetings or my national pharmacy meetings, I get revved, I get excited, because I’m with like-minded people,” she said. “Why is that? Part of it has to do with culture. We are here for a common reason.”

Pages: 1 2 3 | Single Page

Filed Under: ACR Convergence, Legislation & Advocacy, Meeting Reports Tagged With: ACR Convergence 2022, Advocacy, Dr. Kamala Nola

You Might Also Like:
  • Channel Policy Frustrations into Advocacy to Improve Patient Care
  • Why Fellows Should Care about Advocacy
  • Why Fellows Should Care about ACR Advocacy
  • How to Launch Successful Rheumatology Patient Advocacy Programs

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)